United States Biotechnology & Medical Research

Compass Therapeutics, Inc. (CMPX)

Track

Insider trading activity at Compass Therapeutics, Inc. has been inactive over the past three months. The most recent transactions occurred in May and April 2025, involving both executive share purchases and significant sales by institutional shareholders. Given that these activities occurred more than three months ago, no further analysis regarding recent market performance is provided.
Ticker: CMPX Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Compass Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 27 May 2025
Value US$4,754,630.91 | Price 492.10 | Shares 81,301 (-4.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-27 2025-05-27 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
81,301 -4.6%
492.10
US$4,754,631 		81,301 -4.6% 492.10 US$4,754,631
2025-04-11 2025-04-09 S Sale
1.5
GORDON CARL L
Non-Executive Director Large shareholder
91,856 -10.3%
70.01
US$90,231 		91,856 -10.3% 70.01 US$90,231
2025-04-11 2025-04-09 S Sale
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
57,291 -0.4%
89.07
US$3,976,422 		57,291 -0.4% 89.07 US$3,976,422
2025-04-09 2025-04-09 PrS Proposed sale
2.6
OrbiMed Genesis Master Fund, L.P.

Director; Shareholder

Non-Executive Director
3,571,428
1.59
US$5,678,571 		3,571,428 1.59 US$5,678,571
2025-04-09 2025-04-09 PrS Proposed sale
The Biotech Growth Trust PLC

Director; Shareholder

Non-Executive Director
3,571,428
1.59
US$5,678,571 		3,571,428 1.59 US$5,678,571
2025-04-08 2025-04-07 B Purchase
3.3
Anderman Jonathan

Gen Counsel & Corporate Sec

Officer
20,000 +2000.0%
1.54
US$30,800 		20,000 +2000.0% 1.54 US$30,800
2025-04-08 2025-04-07 B Purchase
3.8
Lerner Neil

CHIEF ACCOUNTING OFFICER

Officer
20,000 +6.7%
1.42
US$28,400 		20,000 +6.7% 1.42 US$28,400
2023-03-10 2023-03-10 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
10,000 +0.2%
3.37
US$33,700 		10,000 +0.2% 3.37 US$33,700
2023-02-27 2023-02-27 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.3%
3.98
US$79,600 		20,000 +0.3% 3.98 US$79,600
2023-02-15 2023-02-15 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.3%
3.86
US$77,200 		20,000 +0.3% 3.86 US$77,200
2023-01-31 2023-01-31 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
4.05
US$81,000 		20,000 +0.4% 4.05 US$81,000
2023-01-24 2023-01-24 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
4.19
US$83,800 		20,000 +0.4% 4.19 US$83,800
2022-11-25 2022-11-25 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
2 -0.0%
4.36
US$9 		2 -0.0% 4.36 US$9
2022-11-25 2022-11-23 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
9,569 -0.9%
4.30
US$41,147 		9,569 -0.9% 4.30 US$41,147
2022-11-25 2022-11-22 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
14,929 -1.4%
4.19
US$62,553 		14,929 -1.4% 4.19 US$62,553
2022-11-22 2022-11-21 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
16,035 -1.5%
4.34
US$69,592 		16,035 -1.5% 4.34 US$69,592
2022-11-22 2022-11-18 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
6,226 -0.6%
4.40
US$27,394 		6,226 -0.6% 4.40 US$27,394
2022-11-10 2022-11-08 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
402,000 +2.7%
3.21
US$1,290,420 		402,000 +2.7% 3.21 US$1,290,420
2022-11-10 2022-11-08 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
402,000 +2.7%
3.21
US$1,290,420 		402,000 +2.7% 3.21 US$1,290,420
2022-09-28 2022-09-28 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
10,000 +0.2%
2.32
US$23,200 		10,000 +0.2% 2.32 US$23,200
2022-09-27 2022-09-26 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
2.27
US$34,050 		15,000 +0.3% 2.27 US$34,050
2022-09-08 2022-09-07 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
3.03
US$45,450 		15,000 +0.3% 3.03 US$45,450
2022-09-01 2022-09-01 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
2.83
US$42,450 		15,000 +0.3% 2.83 US$42,450
2022-08-17 2022-08-17 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
3.05
US$45,750 		15,000 +0.3% 3.05 US$45,750
2022-08-10 2022-08-10 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
2.64
US$39,600 		15,000 +0.3% 2.64 US$39,600
2022-08-02 2022-08-01 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
2.58
US$38,700 		15,000 +0.3% 2.58 US$38,700
2022-06-21 2022-06-21 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
2.80
US$56,000 		20,000 +0.4% 2.80 US$56,000
2022-06-17 2022-06-16 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
2.34
US$46,800 		20,000 +0.4% 2.34 US$46,800
2022-06-13 2022-06-13 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
30,000 +0.6%
2.29
US$68,700 		30,000 +0.6% 2.29 US$68,700
2022-06-07 2022-06-06 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
30,000 +0.6%
2.83
US$84,900 		30,000 +0.6% 2.83 US$84,900
2022-06-01 2022-06-01 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
3.03
US$60,600 		20,000 +0.4% 3.03 US$60,600
2022-05-26 2022-05-26 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
3.04
US$60,800 		20,000 +0.4% 3.04 US$60,800
2022-05-24 2022-05-23 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
18,355 +0.4%
2.72
US$49,926 		18,355 +0.4% 2.72 US$49,926
2022-05-17 2022-05-17 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,215 +0.4%
2.47
US$49,931 		20,215 +0.4% 2.47 US$49,931
2022-05-13 2022-05-13 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
30,722 +0.2%
2.49
US$76,498 		30,722 +0.2% 2.49 US$76,498
2022-05-13 2022-05-13 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
30,722 +0.2%
2.49
US$76,498 		30,722 +0.2% 2.49 US$76,498
2022-05-13 2022-05-12 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
97,094 +0.7%
2.35
US$228,171 		97,094 +0.7% 2.35 US$228,171
2022-05-13 2022-05-12 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
97,094 +0.7%
2.35
US$228,171 		97,094 +0.7% 2.35 US$228,171
2022-05-13 2022-05-11 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
64,700 +0.4%
1.79
US$115,813 		64,700 +0.4% 1.79 US$115,813
2022-05-13 2022-05-11 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
64,700 +0.4%
1.79
US$115,813 		64,700 +0.4% 1.79 US$115,813
2022-05-10 2022-05-10 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
27,836 +0.5%
1.80
US$50,105 		27,836 +0.5% 1.80 US$50,105
2022-05-10 2022-05-10 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
24,447 +0.2%
1.60
US$39,115 		24,447 +0.2% 1.60 US$39,115
2022-05-10 2022-05-10 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
24,447 +0.2%
1.60
US$39,115 		24,447 +0.2% 1.60 US$39,115
2022-05-10 2022-05-09 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
90,712 +0.6%
1.56
US$141,511 		90,712 +0.6% 1.56 US$141,511
2022-05-10 2022-05-09 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
90,712 +0.6%
1.56
US$141,511 		90,712 +0.6% 1.56 US$141,511
2022-05-10 2022-05-06 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
10,200 +0.1%
1.63
US$16,626 		10,200 +0.1% 1.63 US$16,626
2022-05-10 2022-05-06 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
10,200 +0.1%
1.63
US$16,626 		10,200 +0.1% 1.63 US$16,626
2021-11-08 2021-11-04 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
3,571,428 +inf%
3.50
US$12,499,998 		3,571,428 +inf% 3.50 US$12,499,998
2021-11-08 2021-11-04 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,785,715 +14.0%
3.50
US$6,250,002 		1,785,715 +14.0% 3.50 US$6,250,002
2021-11-08 2021-11-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
3,571,428 +inf%
3.50
US$12,499,998 		3,571,428 +inf% 3.50 US$12,499,998
2021-11-08 2021-11-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,785,715 +14.0%
3.50
US$6,250,002 		1,785,715 +14.0% 3.50 US$6,250,002
2020-06-23 2020-06-19 B Purchase
Ferneau Philip
Non-Executive Director
250,000 +166.4%
5.00
US$1,250,000 		250,000 +166.4% 5.00 US$1,250,000
2020-06-23 2020-06-19 B Purchase
Sunderland Julie
Non-Executive Director
289,118 +13.1%
5.00
US$1,445,590 		289,118 +13.1% 5.00 US$1,445,590
2020-06-23 2020-06-19 B Purchase
Ferneau Philip
Non-Executive Director
64,066 +2.8%
5.00
US$320,330 		64,066 +2.8% 5.00 US$320,330
2020-06-23 2020-06-19 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,455,132 +12.9%
5.00
US$7,275,660 		1,455,132 +12.9% 5.00 US$7,275,660
2020-06-23 2020-06-19 B Purchase
3.6
Schuetz Thomas J.

Chief Executive Officer

Executive Director
97,431 +2.2%
5.00
US$487,155 		97,431 +2.2% 5.00 US$487,155
2020-06-23 2020-06-19 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,455,132 +12.9%
5.00
US$7,275,660 		1,455,132 +12.9% 5.00 US$7,275,660
Explore more

More insider trading research around Compass Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America